Clinical Scorecard: The Conversations Shaping ASMS 2026

At a Glance

Key Highlights

• Mass spectrometry is expanding in utility and applications across various fields.
• Multiomics approaches are becoming more routine in research, particularly in cancer studies.
• AI is increasingly utilized for data analysis and experimental design, though caution is advised.
• Imaging techniques are advancing, particularly in conjunction with mass spectrometry.
• Uncertainty around federal research funding remains a significant concern for the field.

Guideline-Based Recommendations

Diagnosis

Management

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Not applicable; focus is on research and technology.

Not applicable; focus is on research methodologies.

Clinical Best Practices

Related Resources & Content